Market Tracker

05/27 5:16pm ET

NewLink Genetics Corp (NASDAQ:NLNK)

11.17
Delayed Data
As of May 27
 +0.28 / +2.57%
Today’s Change
9.23
Today|||52-Week Range
56.16
-69.30%
Year-to-Date
No recent news for NewLink Genetics Corp.

Today’s Trading

Previous close10.89
Today’s open10.90
Day’s range10.72 - 11.25
Volume319,986
Average volume (3 months)717,071
Market cap$322.8M
Dividend yield--
Data as of 4:00pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-142.47%
Earnings growth (this year)-114.61%
Earnings growth (next 5 years)--
Revenue growth (last year)-60.31%
P/E ratioNM
Price/Sales15.19
Price/Book1.64

Competitors

 Today’s
change
Today’s
% change
NERVMinerva Neuroscience...-0.48-4.07%
GALEGalena Biopharma Inc+0.03+1.76%
NHTCNatural Health Trend...+0.49+1.73%
AKBAAkebia Therapeutics ...-0.03-0.34%
Data as of 4:00pm ET, 05/27/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)-$0.86
Annual revenue (last year)$68.5M
Annual profit (last year)-$40.4M
Net profit margin-58.95%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President, Director &
Chief Medical Officer
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts